Apyx Medical (APYX) to Release Quarterly Earnings on Wednesday

Apyx Medical (NASDAQ:APYX) is scheduled to be issuing its Q2 2019 quarterly earnings data after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of ($0.18) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Wednesday, May 8th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.18) by $0.04. Apyx Medical had a net margin of 224.06% and a negative return on equity of 12.25%. The company had revenue of $5.82 million during the quarter. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Shares of APYX stock opened at $6.68 on Tuesday. The stock’s fifty day moving average is $6.80. Apyx Medical has a 12-month low of $3.55 and a 12-month high of $8.89. The company has a market capitalization of $251.34 million, a P/E ratio of -23.03 and a beta of 0.13.

Several brokerages have recently issued reports on APYX. Zacks Investment Research downgraded shares of Apyx Medical from a “buy” rating to a “hold” rating in a research report on Monday, July 22nd. TheStreet downgraded shares of Apyx Medical from a “c-” rating to a “d” rating in a research report on Monday, May 20th. Piper Jaffray Companies lowered their price objective on shares of Apyx Medical to $7.00 and set an “overweight” rating for the company in a research report on Wednesday, May 8th. Finally, ValuEngine raised shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research report on Monday, April 29th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. Apyx Medical presently has a consensus rating of “Buy” and an average target price of $7.88.

About Apyx Medical

Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.

Recommended Story: Lock-Up Period Expiration

Earnings History for Apyx Medical (NASDAQ:APYX)

Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.